Osaic Holdings’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Osaic Holdings’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-667	Closed	-$116	–	7726
2023 Q1	$116	Buy	667 +357	+115%	+$199	﹤0.01%	7318
2022 Q4	$0	Buy	310 +272	+716%	+$179	﹤0.01%	7608
2022 Q3	$0	Hold	38	–	–	﹤0.01%	7670
2022 Q2	$0	Hold	38	–	–	﹤0.01%	7747
2022 Q1	$0	Buy	38 +19	+100%	+$119	﹤0.01%	7703
2021 Q4	$0	Buy	+19	New	+$263	﹤0.01%	7704

Osaic Holdings's CDAK Position: Q2 2023 in Review

Osaic Holdings sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2023, closing a stake of 667 shares — an estimated $116 sold.

Osaic Holdings first reported a position in CDAK in Q4 2021 and held it in 6 quarters. The position peaked at $116 in Q1 2023. 1 fund tracked by Wall St. Rank holds CDAK as of Q2 2023.

Osaic Holdings reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Osaic Holdings sold 667 Codiak BioSciences, Inc. Common Stock shares in Q2 2023, an estimated $116.
Osaic Holdings first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Osaic Holdings's Codiak BioSciences, Inc. Common Stock position peaked at $116 in Q1 2023.
1 fund tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.